Lithuanian Prostate Diagnostics Implementation Guide
0.0.1 - ci-build
Lithuanian Prostate Diagnostics Implementation Guide
0.0.1 - ci-build
Lithuanian Prostate Diagnostics Implementation Guide, published by Lithuanian Medical Library. This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7LT/ig-lt-prostate/ and changes regularly. See the Directory of published versions
| Draft nuo 2026-03-31 |
{
"resourceType" : "CodeSystem",
"id" : "prostate-fhir-mapping-target",
"language" : "lt",
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"lt\" lang=\"lt\"><hr/><p><b>Lithuanian</b></p><hr/><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem prostate-fhir-mapping-target</b></p><a name=\"lt-prostate-fhir-mapping-target\"> </a><a name=\"lt-hcprostate-fhir-mapping-target\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Language: en</p></div><p>This case-sensitive code system <code>https://tx.hl7.lt/fhir/CodeSystem/prostate-fhir-mapping-target</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">encounter-period<a name=\"lt-prostate-fhir-mapping-target-encounter-period\"> </a></td><td>Encounter.period</td></tr><tr><td style=\"white-space:nowrap\">encounter-reason<a name=\"lt-prostate-fhir-mapping-target-encounter-reason\"> </a></td><td>Encounter.reasonCode</td></tr><tr><td style=\"white-space:nowrap\">servicerequest-reason<a name=\"lt-prostate-fhir-mapping-target-servicerequest-reason\"> </a></td><td>ServiceRequest.reasonCode</td></tr><tr><td style=\"white-space:nowrap\">observation-psa-serum<a name=\"lt-prostate-fhir-mapping-target-observation-psa-serum\"> </a></td><td>Observation: LOINC 2857-1 PSA (ObservationLt)</td></tr><tr><td style=\"white-space:nowrap\">observation-body-height<a name=\"lt-prostate-fhir-mapping-target-observation-body-height\"> </a></td><td>Observation: body height (LT VitalSigns patterns)</td></tr><tr><td style=\"white-space:nowrap\">observation-body-weight<a name=\"lt-prostate-fhir-mapping-target-observation-body-weight\"> </a></td><td>Observation: body weight (LT VitalSigns patterns)</td></tr><tr><td style=\"white-space:nowrap\">observation-bmi<a name=\"lt-prostate-fhir-mapping-target-observation-bmi\"> </a></td><td>Observation: BMI (derived or LOINC)</td></tr><tr><td style=\"white-space:nowrap\">observation-dre-finding<a name=\"lt-prostate-fhir-mapping-target-observation-dre-finding\"> </a></td><td>Observation: digital rectal examination finding (ObservationLt, exam)</td></tr><tr><td style=\"white-space:nowrap\">observation-prior-psa<a name=\"lt-prostate-fhir-mapping-target-observation-prior-psa\"> </a></td><td>Observation: prior PSA value with effective time</td></tr><tr><td style=\"white-space:nowrap\">observation-mpmri-history<a name=\"lt-prostate-fhir-mapping-target-observation-mpmri-history\"> </a></td><td>Observation or Procedure: prior mpMRI / PI-RADS summary</td></tr><tr><td style=\"white-space:nowrap\">family-member-history-cancer<a name=\"lt-prostate-fhir-mapping-target-family-member-history-cancer\"> </a></td><td>FamilyMemberHistory (Base patterns) for oncologic family history</td></tr><tr><td style=\"white-space:nowrap\">procedure-prior-prostate-surgery<a name=\"lt-prostate-fhir-mapping-target-procedure-prior-prostate-surgery\"> </a></td><td>Procedure: prior prostate surgery</td></tr><tr><td style=\"white-space:nowrap\">procedure-prior-prostate-radiation<a name=\"lt-prostate-fhir-mapping-target-procedure-prior-prostate-radiation\"> </a></td><td>Procedure: prior prostate radiotherapy</td></tr><tr><td style=\"white-space:nowrap\">medicationstatement-anticoagulant<a name=\"lt-prostate-fhir-mapping-target-medicationstatement-anticoagulant\"> </a></td><td>MedicationStatement: anticoagulant use</td></tr><tr><td style=\"white-space:nowrap\">clinical-impression-or-note<a name=\"lt-prostate-fhir-mapping-target-clinical-impression-or-note\"> </a></td><td>Encounter / DocumentReference / ClinicalImpression for free-text programme notes</td></tr><tr><td style=\"white-space:nowrap\">specimen-dimension-or-measurement<a name=\"lt-prostate-fhir-mapping-target-specimen-dimension-or-measurement\"> </a></td><td>Specimen / Observation specimen measurement (TumorMeasurementLtLab, gross)</td></tr><tr><td style=\"white-space:nowrap\">specimen-adequacy-finding<a name=\"lt-prostate-fhir-mapping-target-specimen-adequacy-finding\"> </a></td><td>Observation: specimen adequacy (LT Lab)</td></tr><tr><td style=\"white-space:nowrap\">observation-tumor-treatment-effect<a name=\"lt-prostate-fhir-mapping-target-observation-tumor-treatment-effect\"> </a></td><td>Observation: tumor treatment effect (TumorObservableLtLab)</td></tr><tr><td style=\"white-space:nowrap\">condition-morphology-prostate<a name=\"lt-prostate-fhir-mapping-target-condition-morphology-prostate\"> </a></td><td>Condition / morphology (ProstateConditionLtLab, ICD-O)</td></tr><tr><td style=\"white-space:nowrap\">observation-gleason-isup-prostate<a name=\"lt-prostate-fhir-mapping-target-observation-gleason-isup-prostate\"> </a></td><td>GleasonIsupObservationLtProstate + ProstateIsupGradeGroupVS</td></tr><tr><td style=\"white-space:nowrap\">observation-tumor-microscopic-idc<a name=\"lt-prostate-fhir-mapping-target-observation-tumor-microscopic-idc\"> </a></td><td>TumorObservableLtLab / morphology for IDC</td></tr><tr><td style=\"white-space:nowrap\">observation-tumor-microscopic-cribriform<a name=\"lt-prostate-fhir-mapping-target-observation-tumor-microscopic-cribriform\"> </a></td><td>TumorObservableLtLab / morphology for cribriform</td></tr><tr><td style=\"white-space:nowrap\">observation-pattern4-percent<a name=\"lt-prostate-fhir-mapping-target-observation-pattern4-percent\"> </a></td><td>Observation: Pattern 4 percent band (lab tumour measurement patterns)</td></tr><tr><td style=\"white-space:nowrap\">observation-tumor-burden-percent<a name=\"lt-prostate-fhir-mapping-target-observation-tumor-burden-percent\"> </a></td><td>Observation: tumour percentage in biopsy tissue</td></tr><tr><td style=\"white-space:nowrap\">observation-periprostatic-invasion<a name=\"lt-prostate-fhir-mapping-target-observation-periprostatic-invasion\"> </a></td><td>Observation: periprostatic fat / seminal vesicle invasion (LT Lab tumour findings)</td></tr><tr><td style=\"white-space:nowrap\">observation-perineural-invasion<a name=\"lt-prostate-fhir-mapping-target-observation-perineural-invasion\"> </a></td><td>Observation: perineural invasion finding (LT Lab tumour findings)</td></tr><tr><td style=\"white-space:nowrap\">observation-lymphovascular-invasion<a name=\"lt-prostate-fhir-mapping-target-observation-lymphovascular-invasion\"> </a></td><td>Observation: lymphovascular invasion finding (LT Lab tumour findings)</td></tr><tr><td style=\"white-space:nowrap\">diagnosticreport-pathology-lab<a name=\"lt-prostate-fhir-mapping-target-diagnosticreport-pathology-lab\"> </a></td><td>PathologyReportLtLab</td></tr><tr><td style=\"white-space:nowrap\">composition-pathology-lab<a name=\"lt-prostate-fhir-mapping-target-composition-pathology-lab\"> </a></td><td>PathologyCompositionLtLab</td></tr></table></div>"
},
"url" : "https://tx.hl7.lt/fhir/CodeSystem/prostate-fhir-mapping-target",
"version" : "0.0.1",
"name" : "ProstateFhirMappingTarget",
"title" : "Prostate questionnaire → FHIR mapping target (illustrative)",
"status" : "draft",
"experimental" : true,
"date" : "2026-03-31T08:54:25+00:00",
"publisher" : "Lithuanian Medical Library",
"contact" : [
{
"name" : "Lithuanian Medical Library",
"telecom" : [
{
"system" : "url",
"value" : "https://medicinosnk.lt"
},
{
"system" : "email",
"value" : "info@medicinosnk.lt"
}
]
}
],
"description" : "Target **codes** for **ConceptMap** entries: each code denotes a logical FHIR mapping destination (profile or element path). Used with **prostate-adpp-questionnaire-item** and **prostate-pathology-questionnaire-item** source codes.",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "LT"
}
]
}
],
"caseSensitive" : true,
"content" : "complete",
"count" : 29,
"concept" : [
{
"code" : "encounter-period",
"display" : "Encounter.period"
},
{
"code" : "encounter-reason",
"display" : "Encounter.reasonCode"
},
{
"code" : "servicerequest-reason",
"display" : "ServiceRequest.reasonCode"
},
{
"code" : "observation-psa-serum",
"display" : "Observation: LOINC 2857-1 PSA (ObservationLt)"
},
{
"code" : "observation-body-height",
"display" : "Observation: body height (LT VitalSigns patterns)"
},
{
"code" : "observation-body-weight",
"display" : "Observation: body weight (LT VitalSigns patterns)"
},
{
"code" : "observation-bmi",
"display" : "Observation: BMI (derived or LOINC)"
},
{
"code" : "observation-dre-finding",
"display" : "Observation: digital rectal examination finding (ObservationLt, exam)"
},
{
"code" : "observation-prior-psa",
"display" : "Observation: prior PSA value with effective time"
},
{
"code" : "observation-mpmri-history",
"display" : "Observation or Procedure: prior mpMRI / PI-RADS summary"
},
{
"code" : "family-member-history-cancer",
"display" : "FamilyMemberHistory (Base patterns) for oncologic family history"
},
{
"code" : "procedure-prior-prostate-surgery",
"display" : "Procedure: prior prostate surgery"
},
{
"code" : "procedure-prior-prostate-radiation",
"display" : "Procedure: prior prostate radiotherapy"
},
{
"code" : "medicationstatement-anticoagulant",
"display" : "MedicationStatement: anticoagulant use"
},
{
"code" : "clinical-impression-or-note",
"display" : "Encounter / DocumentReference / ClinicalImpression for free-text programme notes"
},
{
"code" : "specimen-dimension-or-measurement",
"display" : "Specimen / Observation specimen measurement (TumorMeasurementLtLab, gross)"
},
{
"code" : "specimen-adequacy-finding",
"display" : "Observation: specimen adequacy (LT Lab)"
},
{
"code" : "observation-tumor-treatment-effect",
"display" : "Observation: tumor treatment effect (TumorObservableLtLab)"
},
{
"code" : "condition-morphology-prostate",
"display" : "Condition / morphology (ProstateConditionLtLab, ICD-O)"
},
{
"code" : "observation-gleason-isup-prostate",
"display" : "GleasonIsupObservationLtProstate + ProstateIsupGradeGroupVS"
},
{
"code" : "observation-tumor-microscopic-idc",
"display" : "TumorObservableLtLab / morphology for IDC"
},
{
"code" : "observation-tumor-microscopic-cribriform",
"display" : "TumorObservableLtLab / morphology for cribriform"
},
{
"code" : "observation-pattern4-percent",
"display" : "Observation: Pattern 4 percent band (lab tumour measurement patterns)"
},
{
"code" : "observation-tumor-burden-percent",
"display" : "Observation: tumour percentage in biopsy tissue"
},
{
"code" : "observation-periprostatic-invasion",
"display" : "Observation: periprostatic fat / seminal vesicle invasion (LT Lab tumour findings)"
},
{
"code" : "observation-perineural-invasion",
"display" : "Observation: perineural invasion finding (LT Lab tumour findings)"
},
{
"code" : "observation-lymphovascular-invasion",
"display" : "Observation: lymphovascular invasion finding (LT Lab tumour findings)"
},
{
"code" : "diagnosticreport-pathology-lab",
"display" : "PathologyReportLtLab"
},
{
"code" : "composition-pathology-lab",
"display" : "PathologyCompositionLtLab"
}
]
}